- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
XCUR
NASDAQ
Week ended 07 Aug 2026
Weekly Investor Report
Exicure Inc · Healthcare · Biotechnology
Latest close
1.34 USD
-15.9%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -59.7% below the Trend Line and sits at 0.9% of its 52-week range. The latest completed week returned -15.9%, after a -23.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 1d.
Setup score
10
out of 100
Latest Close
1.34 USD
7 Aug 2026
1W Return
-15.9%
latest completed week
4W Return
-23.1%
short-term follow-through
12W Return
-52.6%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-15.9%
Latest completed week; four-week move -23.1%.
Indicator stack
0/24
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.79%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
33 relevant articles in the latest sentiment read.
Event risk
1d
Next report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -59.7% below the Trend Line and sits at 0.9% of its 52-week range. The latest completed week returned -15.9%, after a -23.1% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0012-week average 0.01
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.00Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -23.1% over four weeks, -52.6% over 12 weeks, and -81.9% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.42Latest activity-pressure read.
Pressure change-9.4%Four-week change in activity pressure.
Leadership-71.27Latest relative-leadership reading.
RS change-6.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 09 Aug 2026
Financial statements through 31 Mar 2026
Field coverage 61%
Model confidence 57%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value57/100Relative valuation strength. Underlying universe rank 44; rank 1 is best.
Quality54/100Profitability and accounting quality. Underlying universe rank 47; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth57/100Revenue and earnings growth. Underlying universe rank 44; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- - Price divided by trailing earnings.
- Price / sales
- - Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -124.5% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- - Gross profit retained from each unit of revenue.
- Operating margin
- - Operating profit retained from revenue.
- Free-cash-flow margin
- - Free cash flow generated from revenue.
- Return on invested capital
- - Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- - Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- - Latest one-year free-cash-flow growth.
- Piotroski F-score
- 2/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- 0.0% Net share repurchases relative to market value.
- Shareholder yield
- 0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.3x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity1 / 0
1 acquisitions and 0 disposals in the latest 180-day insider tape.
Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.News sentiment50/100
Weighted news tone is neutral across 33 relevant articles.
4 positive · 23 neutral · 6 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings1dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-85.8%Distance below the 52-week high.
13-week volatility9.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher10 of 2616 weeks finished lower.
Best week+13.5%Week of 29 May.
Worst week-20.4%Week of 3 Jul.
Latest week-15.9%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains4
Flat weeks0
Modest losses2
Sharp losses14
Recent vol9.5%13-week weekly-return volatility.
Base vol11.0%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew8.0% / -9.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average2.6%
Trend breadth54.0%
Trend54.0%active weekly trend signals
MD77.0%positive activity pressure
RS44.0%positive relative leadership
Four-week leaders
IndustryUS Biotechnology
4-week rank- / 100
Group average0.5%
Trend breadth70.0%
Trend70.0%active weekly trend signals
MD64.0%positive activity pressure
RS62.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape11/100
Trend, activity pressure, participation, and risk combine to a 11/100 tape read.
Indicator analysis18/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.00; No reversal markers Next-Week ExpectancyNegative 41.79%Next-week expectancy is negative with a 41.79% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors57/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 47 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 33 relevant articles.
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates Insiders1 / 01 acquisitions and 0 disposals in the latest 180-day insider tape.
Earnings1dNext report is scheduled for 14 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 1.34 USD | -15.9% | 3.34 USD | 5.41 USD | -1.42 | -71.27 | 247.8K | Off |
| 31 Jul 2026 | 1.60 USD | -9.1% | 3.49 USD | 5.43 USD | -1.39 | -65.24 | 174.2K | Off |
| 24 Jul 2026 | 1.76 USD | 4.8% | 3.62 USD | 5.45 USD | -1.36 | -62.64 | 834.5K | Off |
| 17 Jul 2026 | 1.68 USD | -4.0% | 3.76 USD | 5.47 USD | -1.31 | -65.99 | 22.5M | Off |
| 10 Jul 2026 | 1.75 USD | -8.4% | 3.91 USD | 5.50 USD | -1.30 | -67.09 | 193.6K | Off |
| 3 Jul 2026 | 1.91 USD | -20.4% | 4.06 USD | 5.53 USD | -1.30 | -64.43 | 224.8K | Off |
| 26 Jun 2026 | 2.40 USD | 3.9% | 4.16 USD | 5.55 USD | -1.25 | -56.00 | 356.4K | Off |
| 19 Jun 2026 | 2.31 USD | -16.9% | 4.22 USD | 5.58 USD | -1.13 | -60.29 | 237.0K | Off |
| 12 Jun 2026 | 2.78 USD | -4.8% | 4.28 USD | 5.60 USD | -1.17 | -52.23 | 108.6K | Off |
| 5 Jun 2026 | 2.92 USD | -8.5% | 4.31 USD | 5.62 USD | -1.09 | -50.19 | 80.4K | Off |
| 29 May 2026 | 3.19 USD | 13.5% | 4.35 USD | 5.63 USD | -0.90 | -49.92 | 50.7K | Off |
| 22 May 2026 | 2.81 USD | -1.1% | 4.39 USD | 5.64 USD | -0.97 | -56.06 | 80.4K | Off |
| 15 May 2026 | 2.84 USD | -15.7% | 4.46 USD | 5.65 USD | -0.82 | -56.54 | 67.9K | Off |
| 8 May 2026 | 3.37 USD | 4.0% | 4.52 USD | 5.66 USD | -0.71 | -50.19 | 69.7K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.